1. Home
  2. ACHV vs IDE Comparison

ACHV vs IDE Comparison

Compare ACHV & IDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • IDE
  • Stock Information
  • Founded
  • ACHV N/A
  • IDE 2010
  • Country
  • ACHV Canada
  • IDE United States
  • Employees
  • ACHV N/A
  • IDE N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • IDE Finance/Investors Services
  • Sector
  • ACHV Health Care
  • IDE Finance
  • Exchange
  • ACHV Nasdaq
  • IDE Nasdaq
  • Market Cap
  • ACHV 149.6M
  • IDE 176.9M
  • IPO Year
  • ACHV N/A
  • IDE N/A
  • Fundamental
  • Price
  • ACHV $4.33
  • IDE $11.58
  • Analyst Decision
  • ACHV Strong Buy
  • IDE
  • Analyst Count
  • ACHV 5
  • IDE 0
  • Target Price
  • ACHV $14.80
  • IDE N/A
  • AVG Volume (30 Days)
  • ACHV 116.0K
  • IDE 33.5K
  • Earning Date
  • ACHV 11-07-2024
  • IDE 01-01-0001
  • Dividend Yield
  • ACHV N/A
  • IDE 8.83%
  • EPS Growth
  • ACHV N/A
  • IDE N/A
  • EPS
  • ACHV N/A
  • IDE N/A
  • Revenue
  • ACHV N/A
  • IDE N/A
  • Revenue This Year
  • ACHV N/A
  • IDE N/A
  • Revenue Next Year
  • ACHV N/A
  • IDE N/A
  • P/E Ratio
  • ACHV N/A
  • IDE N/A
  • Revenue Growth
  • ACHV N/A
  • IDE N/A
  • 52 Week Low
  • ACHV $3.03
  • IDE $8.61
  • 52 Week High
  • ACHV $5.98
  • IDE $10.46
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 40.62
  • IDE 54.39
  • Support Level
  • ACHV $4.12
  • IDE $11.27
  • Resistance Level
  • ACHV $4.46
  • IDE $11.63
  • Average True Range (ATR)
  • ACHV 0.24
  • IDE 0.19
  • MACD
  • ACHV -0.05
  • IDE -0.02
  • Stochastic Oscillator
  • ACHV 17.65
  • IDE 74.11

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.

Share on Social Networks: